OCWP
CHRS icon

Owl Creek Wealth Partners’s Coherus Oncology CHRS Stock Holding History

Owl Creek Wealth Partners’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$958 Hold
684
– – ﹤0.01% 1216
2026
Q1 		$1.16K Buy
+684
New +$1.22K ﹤0.01% 1152

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Owl Creek Wealth Partners's CHRS Position: Q2 2026 in Review

Owl Creek Wealth Partners held its Coherus Oncology (CHRS) position steady in Q2 2026 at 684 shares worth $958. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

Owl Creek Wealth Partners first reported a position in CHRS in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.16K in Q1 2026. 135 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Owl Creek Wealth Partners held 684 shares of Coherus Oncology worth $958 as of Q2 2026.
  • Owl Creek Wealth Partners left its Coherus Oncology share count unchanged in Q2 2026.
  • Coherus Oncology made up ﹤0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #1216 holding.
  • Owl Creek Wealth Partners first reported a position in Coherus Oncology in Q1 2026 and has held it in 2 quarters since.
  • Owl Creek Wealth Partners's Coherus Oncology position peaked at $1.16K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.